Radical tumor resection of a relapsed high-grade endometrial stromal sarcoma with an extremely rare mutation: a case report
Recurrent or advanced tumors should be treated aggressively with chemotherapy and radiation. Effort for complete resection and targeted therapy should be offered to the patients. Discovery of rare mutations might offer better personalized therapies in the future. Despite its radicality, cytoreductive surgery is a valid option in cases where life quality has severely deteriorated, offering a few qualitative months of life to the patient.
Authors
- Ekaterini Domali (ORCID: https://orcid.org/0000-0001-8899-3040)
- Theodoros Karampitsakos (ORCID: https://orcid.org/0000-0002-4829-9190)
- Anastasios Potiris (ORCID: https://orcid.org/0000-0001-7716-1521)
- Panagiotis Christopoulos (ORCID: https://orcid.org/0000-0003-4112-8396)
- Alexandros Fotiou (ORCID: https://orcid.org/0000-0003-2428-3992)
- Athanasios Zikopoulos (ORCID: https://orcid.org/0000-0002-8372-2433)
- Peter Drakakis (ORCID: https://orcid.org/0000-0002-8923-0333)
- Sofoklis Stavros (ORCID: https://orcid.org/0000-0002-4104-286X)
- Spyridon Topis
- D. Baltogiannis (ORCID: https://orcid.org/0000-0002-0774-6003)
- Charikleia Skentou
Institutions
- University of Ioannina (GR)
- National and Kapodistrian University of Athens (GR)
- Alexandra Hospital (GR)
- Hygeia Hospital (GR)
Publication Details
- Journal
- AME Case Reports
- Published
- 2024-12-11
- DOI
- https://doi.org/10.21037/acr-24-177
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00